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Abstract Heme oxygenase-1 (Hmox1) is a stress-in-
ducible protein crucial in heme catabolism. The end
products of its enzymatic activity possess anti-oxidative,
anti-apoptotic and anti-inflammatory properties. Cardio-
protective effects of Hmox1 were demonstrated in experi-
mental models of myocardial infarction (MI).
Nevertheless, its importance in timely resolution of post-
ischemic inflammation remains incompletely understood.
The aim of this study was to determine the role of Hmox1
in the monocyte/macrophage-mediated cardiac remodeling
in a mouse model of MI. Hmox1 knockout (Hmox1-/-)
and wild-type (WT, Hmox1?/?) mice were subjected to a
permanent ligation of the left anterior descending coronary
artery. Significantly lower incidence of left ventricle (LV)
free wall rupture was noted between 3rd and 5th day after
MI in Hmox1-/- mice resulting in their better overall
survival. Then, starting from 7th until 21st day post-MI a
more potent deterioration of LV function was observed in
Hmox1-/- than in the surviving Hmox1?/? mice. This was
accompanied by higher numbers of Ly6Chi monocytes in
peripheral blood, as well as higher expression of monocyte
chemoattractant protein-1 and adhesion molecules in the
hearts of MI-operated Hmox1-/- mice. Consequently, a
greater post-MI monocyte-derived myocardial macrophage
infiltration was noted in Hmox1-deficient individuals.
Splenectomy decreased the numbers of circulating
inflammatory Ly6Chi monocytes in blood, reduced the
numbers of proinflammatory cardiac macrophages and
significantly improved the post-MI LV function in
Hmox1-/- mice. In conclusion, Hmox1 deficiency has
divergent consequences in MI. On the one hand, it
improves early post-MI survival by decreasing the occur-
rence of cardiac rupture. Afterwards, however, the hearts of
Hmox1-deficient mice undergo adverse late LV remodel-
ing due to overactive and prolonged post-ischemic
inflammatory response. We identified spleen as an impor-
tant source of these cardiovascular complications in
Hmox1-/- mice.
Keywords Cardiac rupture  Heme oxygenase-1 
Macrophages  Monocytes  Myocardial infarction
Introduction
Upon myocardial infarction (MI) immune system becomes
activated by extensive necrosis of cardiomyocytes and
release of damage-associated molecular patterns [16].
Neutrophils are the first immune cells that infiltrate the
damaged tissue as early as 24 h after injury. Then,
3–4 days later inflammatory monocytes are recruited into
ischemic area of the heart. Apparently, overactive and
prolonged immune responses can be responsible for heart
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failure in patients surviving the ischemic episode [13, 21].
Thus, development of strategies targeting particular subsets
of inflammatory cells and providing well-timed resolution
of inflammation may be crucial for proper healing and
recovery.
Heme oxygenase-1 (Hmox1) catalyzes the conversion of
heme to biliverdin, carbon monoxide (CO), and ferrous
iron (Fe2?). Through the first two compounds Hmox1
mitigates cellular injury. This is accomplished by their
antioxidant, anti-apoptotic, and anti-inflammatory effects
[7, 34]. We have previously demonstrated the impaired
wound healing [9, 20] and recovery after hind limb
ischemia [25] in Hmox1 knockout (Hmox1-/-) mice when
compared to their wild-type (WT, Hmox1?/?) littermates.
An important role of this protein was also demonstrated in
different experimental studies on heart damage. Short-term
cardiac stress, induced by ischemia–reperfusion (I/R)
injury resulted in impaired left ventricular (LV) recovery
and increased infarct size in heterozygous Hmox1-deficient
(Hmox1?/-) mice [55]. In contrast, transgenic animals with
cardiac-specific Hmox1 overexpression were better pro-
tected from I/R, with improved contractile recovery and
reduced infarct size, inflammatory cell infiltration, oxida-
tive damage, and apoptosis [54]. Recently, Hmox1 gene
transfer was shown to attenuate post-ischemic inflamma-
tion in both murine and porcine I/R-injured hearts [22]. In
addition, beneficial effects of Hmox1 were demonstrated
also under prolonged ischemia in mice with permanent
ligation of the coronary artery [47]. Myocyte-restricted
Hmox1 transgenic mice exposed to MI exhibited signifi-
cantly improved survival and LV function, lower intersti-
tial fibrosis and oxidative stress. These beneficial effects
were at least partially mediated by CO-dependent inhibi-
tion of mitochondrial permeability transition and apoptosis
[47].
Importantly, the findings in animal models are in
accordance with several clinical investigations, since in
humans HMOX1 gene expression is modulated by a
guanidine thymidine dinucleotide ([GT]n) repeat poly-
morphism in the promoter region (reviewed in: [8]).
Shorter repeats with (GT)n\25 are associated with higher
inducibility and activity of HMOX1. On the other hand, the
longer repeats result in lower HMOX1 expression and
activity and were associated with an increased risk of
cardiovascular disease (reviewed in: [8]). Thus, heme
oxygenase-1 is important for cardioprotection and repair,
but its involvement in the suppression of post-ischemic
inflammation remains incompletely understood.
Murine blood monocytes are generally divided into two
main subpopulations. One is described as non-classical or
non-inflammatory (Ly6C?CD43??; Ly6Clo). These cells
patrol the intravascular endothelial cell surface and clear
dying endothelial cells [37]. Another subset called classical
or inflammatory (Ly6C??CD43?; Ly6Chi) spikes during
acute MI and accumulates in the evolving myocardial
wound [37]. Sometimes, also a third subset is distin-
guished—intermediate monocytes (Ly6C??CD43??; also
Ly6Chi), that are found at a lower frequency and to some
extent resemble the classical monocytes, as they expand
with cytokine treatment and in inflammation [56]. In con-
trast to Ly6Clo, the Ly6Chi monocytes express on their
surface a chemokine receptor CCR2 [43]. Interaction
between CCR2 and its ligand CCL2 (monocyte chemoat-
tractant protein-1, Mcp-1), upregulated in the inflamed
tissue, results in inflammatory monocyte recruitment [10].
It was recently shown that the post-I/R influx of immune
cells, including Ly6Chi monocytes, was further exacerbated
in Hmox1-deficient murine hearts [22]. On the other hand,
overexpression of Hmox1 in the heart with gene therapy
was able to revert this process [22].
Importantly, under inflammatory conditions monocyte-
derived macrophages gradually replenish the population of
cardiac-resident macrophages [15]. The latter ones are
described as embryonically derived and capable of sus-
taining themselves by local proliferation [15]. Importantly,
their substitution with monocyte-derived macrophages may
be responsible for decreased cardiac repair potential [29].
Additionally, mechanical strain rising in the LV wall after
MI, evokes macrophage proliferation [41]. It was demon-
strated that injection of nanoparticle-loaded siRNA tar-
geting CCR2 to the atherosclerotic apolipoprotein
knockout (ApoE-/-) mice with MI reduces the recruitment
of Ly6Chi monocytes, improves the infarct healing and
attenuates the post-MI heart failure [35]. On the other hand,
macrophages are important in resolution of inflammation.
They produce anti-inflammatory cytokines and chemokines
and eliminate tissue debris. In fact, either increased or
insufficient macrophage expansion was demonstrated to
impair tissue healing after cardiac injury [14]. Evidently,
Hmox1 is important for a proper maintenance and function
of macrophages [39, 49, 53].
At steady state, monocytes are produced in the bone
marrow from hematopoietic precursors, but during
inflammation also spleen is involved in generation, depot
and deployment of these cells [45]. The organ may host
extramedullary hematopoiesis thanks to its ability to adopt
hematopoietic stem and progenitor cells (HSPCs) liberated
from the bone marrow in response to ischemic insult.
Several reports demonstrated an important role of Hmox1
also in differentiation of lineage committed progenitors
involved in erythropoiesis, thrombopoiesis, or B cell mat-
uration (reviewed in: [27]). However, involvement of this
protein in monocytes generation and release from spleen
following MI has not yet been investigated.
Thus, the aims of this study were to determine the role
of Hmox1 in post-MI monocytes mobilization and their
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recruitment to injured cardiac muscle, as well as to check
how different populations of cardiac macrophages are
affected after MI in the presence and absence of Hmox1.
Materials and methods
Experimental animals
For our studies we used 12–14-week-old female Hmox1?/?
(WT) and Hmox1-/- specific pathogen-free mice of
C57BL/69FVB background. Age-matched mice were
randomly allocated either to sham or MI surgery. All ani-
mal procedures were in accordance with Guide for the
Care and Use of Laboratory Animals (Directive 2010/63/
EU of European Parliament) and carried out under a license
from the Ethical Committee of the Jagiellonian University.
All animals were maintained under controlled environ-
mental conditions (12 h light/dark cycle, at approx. 23 C),
and provided with standard laboratory food and water
ad libitum.
Myocardial infarction surgery
Myocardial infarction was induced by permanent ligation
of the left anterior descending (LAD) coronary artery as
described previously [36]. Mice were anesthetized by
intraperitoneal injection of 2,2,2-tribromoethanol (400 mg/
kg of body weight). The limb withdrawal response to toe
pinch was monitored to ensure the adequacy of anesthesia.
Then, mice were placed on temperature-controlled, heated
table, intubated and ventilated by connecting the 22G
cannula inside the tracheal tube to a mechanical ventilator
(MiniVent Type 854; respiration rate: 220 breaths/min,
stroke volume 280 ll). The skin and muscles were cut
along a breastbone, on the left side of a chest. Incision
between 4th and 5th rib was made. Ribs were retracted
with surgical threads and heart was exposed. Pericardial
sac was opened, respiration rate was reduced to
150 breaths/min and LAD coronary artery was perma-
nently ligated with 7.0 silk suture. Successful LAD
occlusion was confirmed by an immediate color change of
the myocardium supplied by the vessel from bright red to
white. Initial respiration rate was restored and incisions
between ribs, muscles and skin were closed with 6.0 silk
suture. Mice were disconnected from the lung ventilator to
allow normal breathing. In case of sham operated mice the
procedure was the same, with placing the suture underneath
LAD but without its ligation. Analgesia was applied to all
(sham and MI-operated) animals twice daily for 3 con-
secutive days after surgery by subcutaneous injection of
buprenorphine at the dose of 0.08 mg/kg of body weight.
Splenectomy
During isoflurane anesthesia the abdominal cavity of mice
was opened above the left kidney. Then, the spleen vessels
were carefully cauterized and spleen was removed. One
month later mice were exposed to sham or MI surgeries as
described above.
Detection of cardiac troponin I in plasma
Facial vein puncture was performed intravitally 24 h after
each MI or sham surgery to obtain the peripheral blood
(PB) anticoagulated with heparin (5 U/ml of blood). After
centrifugation (8009g, 10 min) plasma was collected and
stored frozen at -80 C until further analysis. Cardiac
troponin I (cTnI) was assessed in 100 ll of plasma with
ELISA (DRG MedTek) according to vendor’s protocol.
Detection of hypoxic cells
To assess hypoxia of cardiac muscle Hmox1?/? and
Hmox1-/- mice were injected intraperitoneally with
60 mg/kg of body weight of pimonidazole hydrochloride
(Hypoxyprobe, HP, Inc., MA, USA) and analyzed as pre-
viously described [24, 26]. Thirty minutes after HP injec-
tion half of the animals in each group was subjected to
LAD ligation. The other half was sham-operated. Then,
90 min after the surgery (and 2 h after HP injection) mice
were killed for analysis of hypoxic cells with flow
cytometry.
For preparing single cell suspensions from a heart, blood
was washed out by injecting saline containing 0.5 U/ml
heparin through the LV. Next, the whole heart was excised
and both atria carefully cut off. Then, both ventricles were
finely minced and incubated in 3 ml mixture of 5 mg/ml of
collagenase type II (Gibco) and 1.2 U/ml of dispase
(Gibco) in PBS with calcium and magnesium ions (Gibco)
for 1 h at 37 C with gentle agitation. Then, equal volume
of Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco)
supplemented with 10% Fetal Bovine Serum (FBS; Gibco)
was added. Dissociated cells and undigested tissue were
centrifuged at 2009g for 5 min and the pellet was resus-
pended in 5 ml of calcium and magnesium free PBS
(Gibco). Cell/tissue suspensions were filtered through
100 lm cell strainers, centrifuged and resuspended in PBS
containing 2% FBS. Then, the cells were stained for
30 min at 4 C with 7-AAD (7-amino-actinomycin D) for
the exclusion of nonviable cells. Next, the cells were
washed with PBS, fixed and permeabilized for 20 min at
room temperature (RT) with Cytofix/Cytoperm (BD Bio-
sciences) according to vendor’s protocol. After washing,
the cells were incubated with FITC-conjugated anti-HP
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antibody (Clone: 4.3.11.3, Hypoxyprobe, Inc., Mas-
sachusetts, USA) detecting protein adducts of pimonida-
zole in hypoxic tissue. The stained cells were analyzed
using LSRFortessa cytometer (BD Biosciences) and Facs
Diva (BD Biosciences) Software.
Transthoracic echocardiography
Mice were subjected to inhalation anesthesia with 2%
isoflurane (Aerrane, Baxter) in air and immobilized on a
heating platform ventral side up to maintain the body
temperature at 37 ± 0.5 C. Heart rate and respiration
were continuously monitored by ECG electrodes. Mice
chests were shaved and pre-warmed ultrasound gel was
applied to the area of interest. Transthoracic echocardiog-
raphy (TTE) was performed on day 7, 14 and 21 after MI
using a Vevo 2100 system (Visual Sonics, Canada) with a
30-MHz transducer. The heart was first imaged in B-mode
in the parasternal long axis (PSLA) view to examine the
left ventricle (LV). Moreover, parasternal short axis (SAX)
view was obtained at the level of papillary muscles. In case
of each animal two-dimensional (2D) images crossing the
anterior and posterior walls in PSLA and SAX were
recorded. The following parameters were investigated: LV
ejection fraction (LV EF, %), LV fractional shortening (LV
FS, %), LV chamber volume (LV V, ll) and LV internal
diameter (LV ID, mm) during both systole (s) and diastole
(d).
Flow cytometry
At indicated time-points mice were anesthetized with 2%
isoflurane (Aerrane, Baxter) in air and few drops of blood
were collected by facial vein puncture to Microvette 100
EDTA tubes (Sarstedt) for white blood cell (WBC) count
analysis using ABC Vet Hematology Analyzer (Horiba).
Next, mice were euthanized by intraperitoneal injection of
a mixture of ketamine (200 mg/kg of body weight) and
xylazine (40 mg/kg of body weight). Peripheral blood was
collected with a heparinized syringe from vena cava. Then,
the animal was perfused with 5 ml saline containing 0.5 U/
ml heparin through the LV. Heart, spleen, as well as
femora and tibiae from both hind limbs were collected.
Cells were isolated as described below.
Peripheral blood
Heparin blood samples (approx. 500–700 ll) were cen-
trifuged (4 C, 8009g, 10 min) and plasma was collected
and stored frozen at -80 C until further analysis. Then, all
morphotic elements were suspended in 15 ml of hypotonic
19 RBC lysis buffer (formulation of working solution:
150 mM NH4Cl, 10 mM NaHCO3, 1 mM disodium
EDTA, pH 7.4) for red blood cell (RBC) lysis and then
centrifuged. If necessary, the lysis was repeated. After
complete RBC lysis and removal of supernatant, cells were
washed with PBS.
Spleen
The organ was cut in large pieces and pressed against a
100 lm cell strainer. Cells were washed with PBS and
centrifuged. Then, the supernatant was discarded. Red
blood cells were removed as described above. After com-
plete RBC lysis and removal of supernatant, cells were
washed with PBS.
Heart
Single cell suspensions from both ventricles of the heart
were prepared as described in ‘‘Detection of hypoxic
cells’’. Red blood cells were removed as described above.
After complete RBC lysis and removal of supernatant, cells
were washed with PBS.
Bone marrow
Epiphyses of femora and tibiae were cut and bone marrow
was flushed from bones with PBS using a syringe with 30
gauge needle. Next, cells were centrifuged and red blood
cells were removed as described above. After complete
RBC lysis and removal of supernatant, cells were washed
with PBS.
Before staining cells were incubated for 10 min on ice in
PBS containing 2% FBS and anti-mouse CD16/CD32
antibody (clone 93, eBioscience) in concentration recom-
mended by the vendor. Finally, cells were mixed with
adequate panel of antibodies (Suppl. Table 1 and Suppl.
Table 2) and stained for 25 min at 4 C. For monocyte and
macrophage staining, cell suspensions were incubated with
antibodies directed against CD45, Ly6G, Ly6C, NK1.1,
CD11b, CD11c, CD43, MHC II. For HSPCs, cell suspen-
sions were incubated with antibodies directed against lin-
eage markers (Ter119, CD3, B220, CD11b, Gr-1), Sca-1,
CD117 (c-kit), CD34, CD48, CD150 (SLAM). In all
staining procedures live cells were analyzed and dead cells
were excluded by DAPI staining. Gating strategies for
blood and spleen monocytes (Suppl. Figure 1), cardiac
monocytes and macrophages (Suppl. Figure 2) and HSPCs
in bone marrow and spleen (Suppl. Figure 3) are enclosed
to Supplemental Material. The stained cells were analyzed
using LSRFortessa cytometer (BD Biosciences) and Facs
Diva (BD Biosciences) Software.
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Western blotting
Pieces of tissue from infarct area and corresponding heart
tissue from sham-operated mice (n = 2 mice/group) were
collected on day 4, snap-frozen in dry ice and stored at
-80 C. Total protein was isolated by lysis of tissue in 300 ll
of lysis buffer (1% Triton X-100 in PBS with protease inhi-
bitors). Homogenization was performed using Tissue Lyzer
(Qiagen). Protein concentration was determined using bicin-
chonic acid assay (BCA). For collagen type I detection,
samples containing 40 lg of protein were prepared in non-
reducing conditions and resolved in 7.5% SDS-polyacry-
lamide gel electrophoresis (SDS-PAGE) and transferred to
nitrocellulose membrane (wet transfer, 80 V, 2 h). For a-
tubulin detection, samples were prepared in reducing condi-
tions and subjected to the same procedure as described above.
Membranes were blocked with 5% bovine serum albumin
(BSA) in PBS containing 0.05% Tween-20 (collagen type I)
or 5% milk in PBS containing 0.05% Tween-20 (a-tubulin)
for 2 h at room temperature. Then, primary antibodies were
added in 1:500 dilution (collagen type I, Abcam, ab21286) or
1:1000 dilution (a-tubulin, Calbiochem, DM1A) in blocking
buffer and membranes were incubated overnight at 4 C. On
the following day,membranes werewashed 5 times for 5 min
with PBS containing 0.1% Tween-20. In the next step, sec-
ondary antibodies conjugated with horseradish peroxidase
were added in 1:10,000 dilution in blocking buffer for 45 min
at room temperature. After washing steps, chemiluminescent
substrate for HRP activity (Immobilon Western Chemilumi-
nescentHRP substrate,MerckMillipore)was added for 5 min
andmembraneswere developed on photographicmembranes.
Samples collection and histological examination
Histological analyses were performed in frozen sections of
the hearts collected from mice 21 days after MI (n = 3
mice/group). The chest of anesthetized mice was opened
and the heart arrested in diastole by intraventricular (LV)
injection of 30 mM KCl in saline containing 0.5 U/ml of
heparin. The right atrium was then cut and the heart was
perfused with 5 ml of saline supplemented with 0.5 U/ml
of heparin at a pressure similar to the mean arterial pressure
via PE-50 catheter connected to a perfusion apparatus.
After excision, heart was sliced into two transversal sec-
tions at the site of LAD ligation. The part below LAD
ligation was embedded in OCT compound (Tissue-Tek)
and snap-frozen in dry ice.
Assessment of cardiomyocyte hypertrophy
Sections were blocked with 1% BSA in PBS (1 h, RT) and
then incubated with rhodamine-labeled wheat germ
agglutinin (WGA; Vector Laboratories; dilution: 1:100,
30 min, RT). Sections were mounted with DAPI (40,6-di-
amidino-2-phenylindole) containing medium to visualize
nuclei. Analysis was performed at a 2009 magnification
using the ImageJ software by an observer blinded to the
experimental protocol. For each sample, cardiomyocyte
cross sectional area (CSA) was measured in 100 car-
diomyocytes in which the nucleus was centrally located
within the cell, in both the border peri-infarct zone and in
the remote zone. The average regional cross-sectional area
in lm2 were calculated.
Assessment of CD11b? myeloid cells
Sections were blocked with PBS solution containing 10%
goat serum, 1% BSA and 0.1% Triton (1 h 30 min, RT).
After blocking tissue sections were incubated with primary
rat anti-mouse CD11b antibody (BioRad, clone: 5C6;
dilution: 1:200, overnight 4 C). After washing in PBS the
secondary anti-rat antibody (Alexa Fluor 488) was applied
(dilution: 1:400, 1 h 30 min, RT). Sections were mounted
with DAPI-containing medium to visualize nuclei. The
cells were visualized in the peri-infarct zone at a 2009
magnification.
Total RNA isolation, reverse transcription
and quantitative PCR
Pieces of tissue from infarct area of the hearts and corre-
sponding tissue samples from sham-operated and untreated
mice were collected, snap-frozen in dry ice and stored at
-80 C. Total RNA isolation by lysis in 1 ml of Qiazol
(Qiagen) per tissue sample was performed using Tissue
Lyzer (Qiagen) followed by chloroform extraction and
isopropanol precipitation. Concentration and quality of
RNA was determined by 260 and 280 nm absorbance
measurements using NanoDrop Spectrophotometer
(Thermo Fischer Scientific). For cDNA synthesis 1 lg of
RNA was used. Using NCode miRNA First-Strand cDNA
Synthesis Kit (Invitrogen) cDNA was synthesized in total
volume of 15 ll, according to vendor’s protocol. Obtained
template for quantitative PCR (qPCR) was ten times dilu-
ted in ultrapure water. Quantitative PCR (qPCR) was per-
formed using StepOne Plus Real-Time PCR (Applied
Biosystems) with addition of SYBR Green PCR Master
Mix (SYBR Green JumpStartTM Taq, Sigma), 2 ll of
diluted template and specific primers (Suppl. Table 3).
Elongation factor 2 (Ef2) served as a housekeeping gene in
mRNA analyses. In test samples, quantification of gene
expression was calculated based on the comparative CT
(threshold cycle value) method (DCT = CT gene of
interest - CT housekeeping gene). The melting curve
analysis was performed immediately after each qPCR for
the presence of primer dimers or non-specific products.
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Statistical analyses
Statistical analyses were carried out using GraphPad Prism
software version 5 (GraphPad Software, Inc.). Results are
expressed as mean ± SEM unless otherwise stated. First,
values were tested for Gaussian distribution (Kolmogorov–
Smirnov test). For two-group comparisons, an unpaired
t test was applied to normally distributed variables, a
Mann–Whitney test to non-normally distributed variables.
For comparing more than two groups, a one-way ANOVA
followed by Bonferroni’s post hoc test for multiple com-
parisons, was applied. Survival curves were analyzed by
Log-rank test. p\ 0.05 was considered statistically
significant.
Results
Hmox1 deficiency differently influences early
and late post-MI cardiac remodeling
Hmox1-deprived mice and their WT littermates were
subjected to either LAD ligation or sham surgery. We used
pimonidazole hydrochloride to evaluate hypoxia in cardiac
tissue 90 min after surgery. This compound is reductively
activated and forms adducts with thiol groups of macro-
molecules at low oxygen levels [46]. Detection with flow
cytometry revealed that in both genotypes MI significantly
increased the number of cells positive for hypoxic marker
(pimonidazole-protein adducts) when compared to sham-
operation and no difference was observed between
Hmox1-/- and WT mice subjected to LAD ligation
(Fig. 1a). In addition, highly increased, when compared to
sham controls, plasma cardiac troponin I (cTnI) levels were
detected by ELISA on first day after MI (Fig. 1b). We did
not observe any cTnI circulating in the blood of intact
animals (not shown). There was no significant difference
between post-MI cTnI levels in Hmox1-/- and Hmox1?/?
mice (Fig. 1b).
Survival of mice after operation was monitored until the
end of each experiment (maximum of 21 days). We noticed
that all demises occurred only between 3rd and 5th day
after LAD ligation (Fig. 1c). Survival rate of sham-oper-
ated mice, independently of the genotype, was 100%. A
significantly higher mortality post-MI was observed in WT
mice compared to Hmox1-/- (Fig. 1c). Cause of death was
identified as an internal bleeding associated with left ven-
tricular free wall rupture (LVFWR) below the site of
coronary artery ligation. This was confirmed during
necropsy (Fig. 1d–f). In relation to this we checked the
collagen content, as it was previously demonstrated to be
inversely correlated with the incidence of rupture
[5, 18, 19, 50]. Western blot analysis on day 4 post-MI
revealed higher production of collagen type I in the
infarcted area of the heart of Hmox1-deficient mice than of
their WT littermates (Fig. 1g).
TTE revealed reduction of LV EF 7, 14 and 21 days
after MI surgery in mice of both genotypes (compared to
sham-operated individuals), but more severe deterioration
was observed in Hmox1-/- animals (Fig. 2a). In addition,
the Hmox1-deprived mice with MI had significantly
reduced LV FS (Fig. 2b), increased LV Vs and LV Vd
(Fig. 2c, d, respectively), as well as increased LV ID both
in systole (Fig. 2e) and diastole (Fig. 2f), when compared
to intact and sham-operated Hmox1-/- mice.
Cardiomyocyte cell size assessment using WGA stain-
ing showed that in both genotypes on 21st day post-MI
cardiomyocyte size was greater in the peri-infarct than in
the remote zone of the LV (Fig. 2g, h). This late remod-
eling response in the peri-infarct region was more pro-
nounced in Hmox1-/- mice than in their WT littermates
(Fig. 2h).
Increased steady state numbers and post-MI
monocyte mobilization in the absence of Hmox1
Using flow cytometry, we checked the content of the three
major monocyte subsets in peripheral blood following MI.
Monocytes were gated as presented in Fig. 3a and com-
plete gating strategy is depicted in Suppl. Figure 1. Steady
state numbers of classical (Fig. 3b) and intermediate
(Fig. 3c) monocytes in Hmox1-/- mice were approxi-
mately twice as high as those observed in their WT litter-
mates. In Hmox1?/? mice, the numbers of classical
monocytes did not change much throughout the course of
experiment (Fig. 3b). In contrast, the numbers of classical
monocytes in the blood of Hmox1-/- mice were initially
lower (on first day after MI) and then increased over time
reaching over a 3-fold increase when compared to appro-
priate sham controls on day 21 post-MI (Fig. 3b). Similar
pattern was observed for intermediate monocytes (Fig. 3c).
The numbers of non-classical blood monocytes were
comparable between different experimental groups and
only in Hmox1-deficient mice they were transiently
decreased on 4th day post-MI (Fig. 3d).
MI-induced Hmox1 expression is associated
with downregulation of genes involved
in inflammatory cell infiltration
As early as 1 day after induction of MI a robust upregu-
lation of Hmox1 gene expression was observed in the
infarct region of the heart of WT mice. Hmox1 expression
then decreased with time, reaching basal levels around 21st
day (Fig. 4a). There were no significant changes in the
expression of other genes related to iron metabolism, such
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as ferritin heavy chain (Fth1) and heme oxygenase-2
(Hmox2) following LAD ligation (data not shown).
One day after MI there was a robust and comparable in
both genotypes upregulation of Mcp1 in the infarcted
region of the heart (Fig. 4b). Its elevated levels declined
with time and reached the baseline around 21st day post-
MI. Importantly, in case of Hmox1-deficient mice, this
decrease was delayed and on day 4, in contrast to MI-
operated WT mice, there was still a pronounced level of
Mcp-1 transcript detected in Hmox1-/- mice with MI
(Fig. 4b; day 1 vs. day 4 post-MI in Hmox1-/-: p = 0.11;
day 1 vs. day 4 post-MI in Hmox1?/?: p\ 0.01).
Several leukocyte receptors and vascular adhesion
ligands enable leukocyte binding to and passing through
the endothelial layer of blood vessels inside the tissue [3].
We checked the expression of three adhesion molecules
enabling tethering, rolling and stable adherence of the
leukocyte with the subsequent extravasation between
endothelial cells. On day 1, post-MI, the mRNA levels of
intercellular adhesion molecule 1 (Icam1) were signifi-
cantly higher in the cardiac infarcted area of Hmox1-/-
mice than their WT littermates (Fig. 4c). Similar trend was
observed for E-selectin (Esel) (Fig. 4d) and vascular cell
adhesion molecule 1 (Vcam1) (Fig. 4e), the later one
showing different kinetics with a peak expression on day 4.
Lack of Hmox1 is associated with increased
numbers of monocyte-derived cardiac macrophages
following MI
Immunofluorescent detection of CD11b? cells revealed
that on day 21 post-MI, a vast majority of them accumu-
lated in the peri-infarct area of the LV (Fig. 5a). Mono-
cytes and different populations of macrophages were
determined in single-cell suspensions prepared from the
hearts using flow cytometry. The CD45? Ly6G- NK1.1-
CD11b? cells were gated (complete gating strategy is
shown in Suppl. Figure 2). Then, additional markers,
MHC-II and Ly6C, allowed us to distinguish populations
of monocytes (MHC-IIlo Ly6C?) and macrophages (MHC-
II? Ly6C?, MHC-II?? Ly6C? and MHC-II? Ly6C??) in
the heart (Fig. 5b). Independently of the genotype, there
was an increase in the number of monocytes detected in
cardiac muscle 4 days following ischemic insult (Fig. 5c).
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Then, on 21st day their numbers decreased (Fig. 5c).
Regarding macrophages, the numbers of all investigated
subpopulations were comparable in the hearts of intact
mice of both genotypes (Fig. 5d–f). Interestingly, in the
hearts of Hmox1-/- mice on day 21 post-MI, we detected
increased numbers of MHC-II? Ly6C?? macrophage
subset (Fig. 5d). In the hearts of Hmox1?/? mice, both on
day 4 and 21 after surgery, MHC-II? Ly6C?? macro-
phages were found with comparable frequency in sham and
MI-operated individuals (Fig. 5d). The MHC-II? Ly6C?-
subset (Fig. 5e) increased on day 4 post-MI only in WT
mice, whereas MHC-II?? Ly6C? subset (Fig. 5f) did not
differ significantly on day 4 and 21 post-MI neither in
Hmox1?/? nor Hmox1-/- mice.
Additionally, we found that among MHC-II? Ly6C??
(Fig. 5g), MHC-II? Ly6C? (Fig. 5h) and MHC-II?? Ly-
6C? (Fig. 5i) cardiac macrophage populations, CD11c?
subsets expanded. Significant differences were observed
between sham- and MI-operated Hmox1-/- mice (Fig. 5i,
day 4; g–i, day 21). Less pronounced increases were found
between sham- and MI-operated Hmox1?/? mice (Fig. 5h,
i, day 21).
More active hematopoiesis in the bone marrow
of Hmox12/2 mice at steady state and after injury
Next, we investigated the first putative source of mono-
cytes—the bone marrow. Several cell populations at dif-
ferent levels of the hematopoietic hierarchy were analyzed
(Suppl. Figure 3 shows detailed gating strategy). In gen-
eral, all inspected HSPC populations were more numerous
in the bone marrow of Hmox1-/- mice (Fig. 6a–g). By
definition, all functional hematopoietic stem cells (HSCs)
are described as the population of bone marrow cells that
does not express the cell-surface markers normally present
on lineage (Lin) committed hematopoietic cells, but does
express high levels of stem-cell antigen 1 (Sca-1) and c-kit
[51]. In the bone marrow, the number of SKL cells (Sca-1?
c-kit? Lin-; Fig. 6a) increased on day 4 and remained
elevated up to day 21 independently of the surgical
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procedure (sham or MI) in Hmox1?/? mice, whereas in
Hmox1-/- individuals similar numbers of these cells were
found throughout the course of the experiment. Neverthe-
less, at the end of experiment (day 21) the number of SKL
cells was higher in Hmox1-/- mice compared to their WT
littermates subjected to MI. Because only some phenotypic
SKL have long-term repopulating activity, they can be
further subdivided into long-term (LT)-HSC and short-term
0
200
400
600
*
intact
sham
MI
+ + - - - -
+ + ----
+ +----
day 21
- - - -
+ + --
+ +--
- - - -
+ + --
+ +--
day 4day 1
no
n-
cl
as
si
ca
lm
on
oc
yt
es
pe
r µ
lo
fb
lo
od
0
300
600
900
1200
*
**
*
**
intact
sham
MI
+ + - - - -
+ + ----
+ +----
day 21
- - - -
+ + --
+ +--
- - - -
+ + --
+ +--
day 4day 1
*
cl
as
si
ca
lm
on
o c
yt
es
pe
r µ
l o
fb
lo
od
0
100
200
300
400 ***
*
**
intact
sham
MI
+ + - - - -
+ + ----
+ +----
day 21
- - - -
+ + --
+ +--
- - - -
+ + --
+ +--
day 4day 1
*
***
*
**
in
te
rm
ed
ia
t e
m
on
o c
yt
es
pe
r µ
lo
fb
lo
od
D
A B
C
+ + - -CD45 CD11b Ly6G NK1.1
Hmox1-/-
Hmox1+/+
Fig. 3 Increased steady state
and post-MI numbers of
monocytes in the absence of
Hmox1. a Schematic
representation of different
populations of blood monocytes
based on the expression of
CD43 and Ly6C markers. Flow
cytometric analysis of
b classical monocytes (CD45?
CD11b? Ly6G- NK1.1-
Ly6C?? CD43?),
c intermediate monocytes
(CD45? CD11b? Ly6G-
NK1.1- Ly6C?? CD43??) and
d non-classical monocytes
(CD45? CD11b? Ly6G-
NK1.1- Ly6C? CD43??) in the
peripheral blood of mice after
LAD ligation or sham surgery
(n = 4–9 mice per group). Data
represented as a number of cells
per 1 ll of peripheral blood.
*p\ 0.05, **p\ 0.01,
***p\ 0.0001
intact day 1 day 4 day 21
0.00
0.02
0.04
0.06
††
E
se
l/E
f2
re
l.
ex
pr
es
si
o n
intact day 1 day 4 day 7 day 21
0.00
0.05
0.10
0.15
0.20
0.25
***
*
†††
*
††
H
m
ox
1/
E
f2
re
l.
ex
pr
es
si
on
intact
0.00
0.02
0.04
0.06
†
V
ca
m
1/
E
f2
re
l.
ex
pr
es
si
on
intact day 1 day 4 day 21
0.000
0.004
0.008
0.012
0.016
††
#
Ic
am
1/
E
f2
re
l.
ex
pr
es
si
on
intact day 1 day 4 day 21
0.00
0.05
0.10
0.15
0.20
†††
†††
**
***
††
M
cp
1/
E
f2
re
l.
ex
pr
es
si
on
D
A B
C E
Hmox1+/+ sham
Hmox1+/+ MI
Hmox1-/- sham
Hmox1-/- MI
Fig. 4 Expression of genes involved in inflammatory cell infiltration
inversely correlates with Hmox1 expression. The qPCR for a Hmox1,
b Mcp1, c Icam1, d Esel, e Vcam1 in the infarcted area (or
corresponding area in sham-operated and intact controls) of the heart
at indicated time points after surgery (n = 3–6 mice/group).
*p\ 0.05, **p\ 0.01, ***p\ 0.0001; *vs. appropriate sham con-
trol, vs. appropriate intact control, #vs. other MI
Basic Res Cardiol  (2017) 112:39 Page 9 of 19  39 
123
(ST)-HSC, which have only limited self-renewal activity
[51]. Among SKL cells, the number of LT-HSC (SKL
CD34- CD48- CD150?; Fig. 6b) was higher in intact
Hmox1-/- than in intact WT mice, however, their numbers
were not significantly changed after MI in both genotypes.
Higher ST-HSC (SKL CD34? CD48- CD150?; Fig. 6c)
numbers were detected in Hmox1-/- than in WT mice
(intact and on day 21 independently of the surgical pro-
cedure). Higher numbers of hematopoietic progenitor cells
(SKL CD34? CD48- CD150-; HPC; Fig. 6d) and multi-
potent progenitors (SKL CD34? CD48? CD150-; MPP;
Fig. 6e) were detected in WT mice on day 4 and 21
independently of the surgical procedure (sham or MI) when
compared to intact WT individuals. On day 21 post-MI,
MPPs were more frequently detected in the bone marrow
of Hmox1-/- than WT mice (Fig. 6e, day 21). The num-
bers of more differentiated hematopoietic progenitors (Sca-
1- c-kit? Lin-; KL, Fig. 6f) were transiently increased in
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Hmox1-/- mice on day 4 and a decline was observed on
day 21 post-MI (Fig. 6f). Importantly, the numbers of
granulocyte-monocyte progenitors (CD34? CD48??
CD150-; GMP; Fig. 6g) increased during the course of the
experiment in both genotypes. However, significant dif-
ference between Hmox1?/? and Hmox1-/- mice subjected
to MI was observed only on day 4 (Fig. 6g).
Generation and release of Ly6Chi monocytes
from the spleen of Hmox12/2 mice in response
to cardiac injury
Previously, it was shown that approximately 50% of all
monocytes recruited to the heart derive from a splenic
reservoir [45]. A detailed analysis of different populations
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Fig. 6 Lack of Hmox1 is
associated with higher steady
state and post-MI numbers of
selected hematopoietic stem and
progenitor cell populations in
bone marrow. Flow cytometric
analysis of a SKL cells (CD45?
Sca-1? c-kit? Lin-), b long-
term HSC (LT-HSC; CD45?
Sca-1? c-kit? Lin- CD34-
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CD150?), d hematopoietic
progenitors (HPC; CD45? Sca-
1? c-kit? Lin- CD34? CD48-
CD150-), e multipotent
hematopoietic progenitors
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Lin- CD34? CD48? CD150-),
f progenitor cells lacking Sca-1
(KL; CD45? Sca-1- c-kit?
Lin-), g granulocyte-monocyte
progenitor cells (GMP; CD45?
Sca-1- c-kit? Lin- CD34?
CD48?? CD150-) in the bone
marrow of mice after LAD
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(n = 4–10 mice/group). Data
represented as a number of cells
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of splenic monocytes revealed significantly higher numbers
of classical and intermediate monocyte subsets in intact
Hmox1-/- mice than in their intact WT littermates
(Fig. 7a, b). The numbers of classical monocytes in the
spleens of Hmox1?/? mice were the highest in the end of
experiment (Fig. 7a, day 21). Additionally, a significantly
lower number of these cells was noted in the spleens of
Hmox1-/- mice with MI when compared to MI-operated
WT individuals (Fig. 7a, day 21). Non-classical monocytes
in the spleen did not differ significantly after LAD ligation
in Hmox1-/- mice at any of the time-points analyzed,
whereas in WT we observed a significant difference
between sham- and MI-operated individuals on day 21
(Fig. 7c).
Spleen is able to support hematopoietic function of the
bone marrow [11, 40]. Thus, we analyzed different popu-
lations of HSPCs also in the spleen. After MI, numbers of
SKL cells in spleen changed over time. In spleens of mice
of both genotypes subjected to LAD ligation, on first day
there was an increase of SKLs, and then, on day 4, this
population significantly declined in number. On day 21
SKLs re-appeared in both WT and Hmox1-/- mice, but the
significant difference between sham- and MI-operated
individuals was noticed only for Hmox1?/? mice (Fig. 8a).
Among SKLs, similar pattern (apart from day 21) was
observed for LT-HSCs (Fig. 8b). However, especially at
steady state, these cells were very rare in the spleen
(Fig. 8b). On day 21 ST-HSCs (Fig. 8c), HPCs (Fig. 8d)
and MPPs (Fig. 8e), expanded after MI in WT mice,
whereas their numbers were comparable between sham-
and MI-operated Hmox1-/- individuals. Similarly, more
differentiated progenitors (KL cells, Sca-1- c-kit? Lin-,
Fig. 8f) and GMPs (Fig. 8g) were in general less numerous
in the spleens of Hmox1-/- mice on day 21 post-surgery
(both sham and MI) when compared to corresponding WT
mice. Similar genotype-dependent difference was observed
also in steady-state numbers of GMPs (Fig. 8g).
Splenectomy differently influences the post-MI
monocyte/macrophage numbers and LV function
in Hmox11/1 and Hmox12/2 mice
We next evaluated animals splenectomized one month
before either sham or MI surgeries. Removal of spleen
differently affected the LV EF in Hmox1?/? and
Hmox1-/- mice starting from 7th until 21st day post-MI
(Fig. 9a, b). In splenectomized WT mice there was a trend
towards greater reduction of post-MI LV function than in
non-splenectomized individuals of the same genotype
subjected to LAD ligation (Fig. 9a). Opposite effect was
observed in Hmox1-deficient mice where splenectomy was
associated with significantly improved post-MI LV EF
(Fig. 9b) suggesting an important role of spleen in post-MI
heart failure progression in Hmox1-/- mice.
Next, we analyzed different subsets of blood mono-
cytes and cardiac macrophages in splenectomized
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Fig. 7 Increased steady state
and decreased late post-MI
monocyte numbers in spleens of
Hmox1-/- mice. Flow
cytometric analysis of
a classical (CD45? CD11b?
Ly6G- NK1.1- Ly6C??
CD43?), b intermediate
(CD45? CD11b? Ly6G-
NK1.1- Ly6C?? CD43??) and
c non-classical (CD45?
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the spleens of mice after LAD
ligation or sham surgery
(n = 4–10 mice/group). Data
represented as a number of cells
per spleen. *p\ 0.05,
**p\ 0.01, ***p\ 0.0001
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animals 21 days after LAD ligation. In Hmox1?/? mice
removal of spleen resulted in significantly increased post-
MI numbers of classical (Fig. 9c) and non-classical
(Fig. 9e) monocytes, while intermediate monocytes
(Fig. 9d) remained unchanged when compared to sham-
operated splenectomized controls. Flow cytometric anal-
ysis of myocardium revealed significantly increased
MHC-II? Ly6C?? (Fig. 9f) and MHC-II?? Ly6C?
(Fig. 9h) macrophage subsets in splenectomized WT
mice after MI. Among all analyzed macrophage popu-
lations the CD11c? subsets remained unchanged in MI-
operated Hmox1?/? mice when compared to non-
splenectomized individuals of the same genotype sub-
jected to LAD ligation.
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Removal of spleen in Hmox1-/- mice did not signifi-
cantly change the post-MI numbers of neither classical
(Fig. 9c) nor non-classical (Fig. 9e) blood monocytes when
compared to sham-operated splenectomized controls
21 days post-surgery. Interestingly, however, the numbers
of intermediate monocytes (Fig. 9d) were markedly
reduced after spleen removal (both in sham- and MI-op-
erated Hmox1-/- individuals). Flow cytometric analysis of
different subpopulations of cardiac macrophages revealed
that there were no changes in the numbers of MHC-II?
Ly6C?? (Fig. 9f), MHC-II? Ly6C? (Fig. 9g) and MHC-
II?? Ly6C? (Fig. 9h) subsets in splenectomized
Hmox1-/- mice with MI when compared to non-splenec-
tomized individuals of the same genotype subjected to
LAD ligation. Concomitantly, we observed a potent
reduction of MHC-II? Ly6C?? CD11c? (Fig. 9i), MHC-
II? Ly6C? CD11c? (Fig. 9j) and MHC-II?? Ly6C?
CD11c? (Fig. 9k) macrophage subsets following removal
of spleen in MI-operated Hmox1-/- mice when compared
to non-splenectomized individuals of the same genotype
subjected to MI.
Discussion
Following cardiac ischemia, the immune system has an
important and complex role in driving the healing of
injured myocardium. Better understanding of these multi-
faceted cellular and molecular interactions may help to
prevent the unwanted inflammatory damage, adverse car-
diac remodeling and heart failure after ischemic episode.
Here we report that Hmox1 has a dual role in MI. On
one hand, its deficiency is associated with better overall
survival in the first 3–5 days post-ischemia due to much
lower incidence of LVFWR. On the other hand, within the
next few days Hmox1-/- animals develop greater LV
dysfunction than the surviving Hmox1?/? mice. This
phenomenon was associated with increased post-MI
mobilization of inflammatory Ly6Chi monocytes. Their
increased cardiac recruitment resulted in a greater abun-
dance of inflammatory MHC-II?? Ly6C? CD11c? mac-
rophages in the hearts of Hmox1-deficient mice.
Importantly, removal of splenic reservoir of monocytes
limited the adverse late post-ischemic LV remodeling in
Hmox1-/- mice.
In this study we used two methods to confirm the effi-
cacy of the MI surgery and comparable in both genotypes
initial infarct size. Measurement of hypoxic cells with
hypoxia marker (pimonidazole hydrochloride) enables
post-mortem analysis as early as 90 min after ischemia
[24, 26] and may constitute a good alternative for histo-
logical methods determining the infarct size, i.e., triph-
enyltetrazolium chloride (TTC) staining [2]. The use of
hypoxyprobe showed comparable numbers of hypoxic cells
in the hearts of WT and Hmox1-deficient mice shortly after
LAD ligation. The other measurement, evaluation of cTnI
in the peripheral blood, was even more useful as mice with
improperly induced MI, what sometimes happens due to
anatomical variability of the left coronary artery branches
[1], had cTnI at the level of sham-operated animals and
thus were excluded from further investigation.
Previous studies demonstrated the cardioprotective
action of Hmox1 in both short-term [22, 54, 55] (I/R) and
long-term [47] (permanent LAD ligation) ischemic cardiac
stress. This can be attributed to the antioxidant, anti-
apoptotic, and anti-inflammatory effects of the end-prod-
ucts of heme catabolism (biliverdin/bilirubin and CO)
[7, 34]. Additionally, Hmox1 may also act independently
of enzymatic function, as its truncated form is found in the
nucleus where it can regulate transcription factors involved
in the antioxidant response [31]. In our study, Hmox1 gene
was strongly upregulated in the hearts of WT mice 1 day
after MI. Then, the expression decreased with time reach-
ing the baseline on day 21 post-surgery. In fact, Hmox1
gene contains one of the most regulated promoters identi-
fied so far. In addition to its substrate heme, several other
compounds can also upregulate Hmox1 expression, just to
mention reactive oxygen species, inflammatory cytokines
or hypoxia in rodents [33]. All of these above-mentioned
appear and can induce Hmox1 expression under ischemic
stress.
In the present study, we observed much lower occur-
rence of LVFWR and better overall survival in the first
3–5 days after permanent LAD ligation in mice deprived of
Hmox1. According to clinical data, cardiac rupture most
often occurs in patients with a large ST elevation MI
(STEMI) and over the past few decades its occurrence has
been greatly reduced due to higher use of reperfusion
procedures and pharmacotherapy [17]. Thus, the observed
difference is mostly related to our experimental model of
MI associated with a prolonged ischemia, whereas in short-
term cardiac stress following I/R injury such differences
bFig. 9 Splenectomy changes the post-MI patterns of mono-
cytes/macrophages and LV function in Hmox1?/? and Hmox1-/-
mice. LV EF in splenectomized vs. non-splenectomized a Hmox1?/?
and b Hmox1-/- mice monitored for 21 days post-sham or -MI
surgery. Flow cytometric analysis of c classical (CD45? CD11b?
Ly6G- NK1.1- Ly6C?? CD43?), d intermediate (CD45? CD11b?
Ly6G- NK1.1- Ly6C?? CD43??) and e non-classical (CD45?
CD11b? Ly6G- NK1.1- Ly6C? CD43??) monocytes in the blood.
Subsets of cardiac macrophages: f MHC-II? Ly6C??, g MHC-II?
Ly6C?, h MHC-II?? Ly6C?, i MHC-II? Ly6C?? CD11c?, j MHC-
II? Ly6C? CD11c?, k MHC-II?? Ly6C? CD11c? at 21 days after
LAD ligation or sham surgery (n = 3–9 mice/group). Data repre-
sented as c–e a number of cells per 1 ll of peripheral blood and f–k a
number of cells detected in heart. *p\ 0.05, **p\ 0.01,
***p\ 0.0001. #vs. corresponding cardiac surgery in non-splenec-
tomized mice
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may be covert. In animals, the likelihood of rupture after
MI depends on species, strain, gender, and age (reviewed in
Ref. [42]). Experimental studies identified several gene
products influencing rates of cardiac rupture (reviewed in
Ref. [42]). Among these, decreased collagen content has
been associated with infarct expansion and rupture
[5, 18, 19, 50]. Hmox1 was previously described as vul-
nerable atherosclerotic plaque defining agent [6] and its
overexpression with gene therapy decreased interstitial
collagen in rat hearts exposed to I/R injury [32]. Moreover,
it was recently shown that Hmox1-/- mice exhibit a higher
than WT mice degree of collagen deposition in their atria
[52]. To the best of our knowledge, here we report for the
first time that the lack of Hmox1 significantly lowers the
risk of LVFWR after permanent LAD ligation. The pro-
tective effect on this early rapid and deadly LV remodeling
was associated with greater than in WT mice collagen type
I production in the damaged area of the heart.
Next, starting from 7th until 21st day post-MI with TTE
we observed an opposite effect—significantly impaired LV
function in Hmox1-/- mice, greater than in WT individ-
uals. WGA staining performed 21 days after MI revealed
greater cardiomyocyte hypertrophy in the LV peri-infarct
zone of Hmox1-deficient mice than in their WT littermates.
Hmox1 was previously shown to modulate the late post-MI
remodeling by attenuation of LV hypertrophy and inter-
stitial fibrosis [38, 47]. These beneficial effects of Hmox1,
and particularly one of its reaction product—CO, are at
least partially mediated by regulation of cell cycle of dif-
ferent cells residing the heart—vascular smooth muscle
cells (VSMCs), fibroblasts, endothelial cells and car-
diomyocytes [28, 30, 32, 48]. Additionally, cardiac
monocyte-derived macrophages may intensify the post-MI
LV remodeling and heart failure due to excessive immune
response [29].
Increased number of classical Ly6Chi monocytes circu-
lating in the blood of Hmox1-deficient mice and their
enhanced post-I/R cardiac influx was recently associated
with increased infarct size and impaired LV wall motion
[22]. In the present study we also detected greater numbers
of inflammatory classical and intermediate Ly6Chi mono-
cytes in the blood of Hmox1-/- when compared to
Hmox1?/? mice both at steady state and 21 days post-MI.
In addition, this was associated with prolonged upregula-
tion of cardiac Mcp-1 gene expression, greater induction of
adhesion molecules and increased numbers of monocyte-
derived macrophages in the hearts of Hmox1-deficient
mice with MI. Particularly, we noticed expansion of MHC-
II? Ly6C?? macrophage population starting from 4th until
21st day post-MI. It is well established that Ly6Chi cells are
the predominant subtype during the first few days post-MI,
after which time Ly6Clo macrophages begin to predomi-
nate [37]. Additionally, among MHC-II? Ly6C??, MHC-
II? Ly6C? and MHC-II?? Ly6C? macrophages, the
CD11c? subsets expanded. On day 21, there was a sig-
nificant difference in the number of all analyzed CD11c?
macrophage populations between WT and Hmox-1-defi-
cient mice subjected to MI. Contrary to cardiac-resident
macrophages, the monocyte-derived macrophages were
shown to strongly express on their surface CD11c antigen
[14]. The CD11c? macrophages represent a classical
proinflammatory phenotype capable of efficiently produc-
ing IL-1b, TNF-a and IFN-c [23]. Moreover, elevated
levels of MHC II (and other co-stimulatory molecules) on
the surface (MHC??) make these cells highly professional
antigen-presenting cells capable of promoting strong lym-
phocyte responses [23]. Expansion of these proinflamma-
tory macrophage subsets in the infarcted hearts of Hmox1-
deficient mice indicates their involvement in the heart
failure progression.
Hmox1 is a critical regulator of the balance between
self-renewal and differentiation of HSPCs under environ-
mental stress as its haplodeficiency (Hmox1?/-) was
associated with premature depletion of HSC reserve fol-
lowing repeated myelotoxic injuries [4]. In the bone mar-
row of Hmox1-deficient mice at steady state we detected
more numerous populations of all investigated HSPCs.
Moreover, GMPs on day 4 and SKL, ST-HSC, MPP on day
21 post-MI were more abundant in the bone marrow of
Hmox1-/- than Hmox1?/? mice. This indicates a more
active hematopoiesis in the bone marrow of Hmox1-defi-
cient mice subjected to MI.
In addition to bone marrow [12], spleen may contribute
to the post-MI monocyte mobilization. This organ was
described as a site for storage and rapid deployment of
monocytes [45]. In this way, injury-induced monocy-
topoiesis usually does not lead to serious disturbances in
generation of lymphocytes, erythrocytes and platelets in the
bone marrow. In the spleen of intact Hmox1-deprived
animals we detected higher numbers of different monocyte
subsets—especially classical and intermediate which were
significantly increased. On day 21 post-MI the numbers of
classical and intermediate monocytes in spleens of
Hmox1-/- mice were lower than in their WT littermates.
At the same time after MI, the numbers of these two
monocyte subsets were increased in the blood of Hmox1-
deficient mice, what may be a consequence of their
departure from the spleen.
It was previously shown that following MI, upstream
progenitors are mobilized from the bone marrow niches
and engrafted in the spleen [11, 40]. Activation of such
supportive hematopoiesis leads to generation of surplus
circulating monocytes. Analysis of different populations of
HSPCs in spleen revealed an increase of SKLs and, among
them LT-HSCs, on 1st day following MI in spleens of mice
of both genotypes. Then, their numbers markedly dropped
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on day 4 indicating their exploitation in extramedullary
hematopoiesis in the spleen. What is more, significantly
lower steady state numbers of GMPs in Hmox1-/- than
Hmox1?/? mice were found. All these observations sup-
port a hypothesis, that the process of generation and lib-
eration of monocytes from the spleens of Hmox1-/- mice
after MI is so intense, that in a consequence it leads to a
rapid exhaustion of splenic reserve of hematopoietic
progenitors.
We finally demonstrated an important role of spleen in
the post-MI mobilization of the proinflammatory Ly6Chi
monocytes and heart failure progression in splenectomized
Hmox1-/- mice. Splenectomy significantly decreased the
numbers of intermediate Ly6Chi monocytes and prevented
the post-MI expansion of the two inflammatory Ly6Chi
(classical and intermediate) subsets in the blood of Hmox1-
deficient mice. As a consequence, the post-MI numbers of
proinflammatory monocyte-derived macrophages, includ-
ing CD11c? subsets of all analyzed macrophage popula-
tions were decreased in the hearts of splenectomized
Hmox1-/- mice and their heart function improved signif-
icantly when compared to non-splenectomized MI-oper-
ated Hmox1-deficient individuals. In contrast, removal of
spleen in Hmox1?/? mice resulted in excessive post-MI
numbers of classical Ly6Chi and non-classical Ly6Clo
monocytes, increased numbers of monocyte-derived car-
diac macrophages (but not in the CD11c? subsets) and a
tendency towards greater LV dysfunction when compared
to non-splenectomized MI-operated WT mice. Such dis-
crepancies between splenectomized Hmox1?/? and
Hmox1-/- mice may suggest that Ly6Chi classical and
intermediate monocytes may have different origin. Inter-
mediate monocytes in Hmox-1-deficient mice seem to
derive from the spleen, as their numbers are dramatically
reduced following splenectomy. A potent increase in the
numbers of classical monocytes in the blood of splenec-
tomized WT mice after MI indicates their bone marrow
origin. This can further implicate different function of
these cells in the injured cardiac muscle. In fact, Dutta et al.
described different mRNA profile in monocytes of splenic
and bone marrow origin and shown similarities in inflam-
matory gene expression between monocytes isolated from
the spleen and Ly6Chi monocytes isolated from
atherosclerotic plaque after MI [11].
A limitation of this study is that the mechanism by
which Hmox1 regulates the production of monocytes still
remains to be elucidated. The monocyte-macrophage
lineage commitment at steady-state and during inflam-
mation undergoes a tight control intrinsically via several
transcription factors and extrinsically via different
cytokines/growth factors [44]. Thus, it would be inter-
esting to investigate some of these mechanisms in the
future.
In conclusion, our findings demonstrate a dual role of
Hmox1 in MI. On one hand Hmox1 deficiency improves
early post-MI survival by decreasing the occurrence of
LVFWR. Afterwards, however, the absence of Hmox1 is
associated with adverse late LV remodeling and severe
heart failure after MI. This was associated with an
increased monocyte mobilization to the blood and exag-
gerated myocardial macrophage infiltration. We identified
spleen as an important source of the surplus circulating
inflammatory Ly6Chi monocytes contributing to the severe
LV dysfunction after MI in Hmox1-/- mice. Our findings
may indicate that any therapeutic strategies aimed at
modulation of Hmox1 expression in the heart post-MI
should be applied in a timely manner.
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